← FDA DRUG APPROVALS

FDA NDA · NDA022044

JANUMET

sitagliptin and metformin hydrochloride

Sponsor: MSD SUB MERCK

APPLICATION
NDA022044
TYPE
NDA
ORIGINAL APPROVAL
2007-03-30
LATEST ACTION
2022-06-21
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription

Products

JANUMET · ReferencePrescription
METFORMIN HYDROCHLORIDE 500MG, SITAGLIPTIN PHOSPHATE EQ 50MG BASE · TABLET · ORAL
JANUMET · ReferencePrescription
METFORMIN HYDROCHLORIDE 1GM, SITAGLIPTIN PHOSPHATE EQ 50MG BASE · TABLET · ORAL

Approval history

2022-06-21Labeling · Supplement 52 · standardLetterAP
2021-11-04Labeling · Supplement 51 · standardLetterAP
2020-12-04Efficacy · Supplement 48 · priorityLabelAP
2019-08-12Efficacy · Supplement 46 · standardLetterAP
2019-07-01Labeling · Supplement 47 · 901 requiredLetterAP
2018-02-09Labeling · Supplement 43 · standardLabelAP
2017-08-10Labeling · Supplement 42 · standardLabelAP
2017-01-18Labeling · Supplement 40 · standardLabelAP
2017-01-18Labeling · Supplement 39 · 901 requiredLabelAP
2015-08-28Labeling · Supplement 35 · 901 requiredLabelAP
2015-06-12Manufacturing (CMC) · Supplement 33 · standardAP
2015-04-27Labeling · Supplement 34 · standardLabelAP
2015-01-05Manufacturing (CMC) · Supplement 32 · standardAP
2014-03-18Manufacturing (CMC) · Supplement 30 · standardAP
2013-09-11Labeling · Supplement 29 · standardLabelAP
2013-06-28Manufacturing (CMC) · Supplement 28 · standardAP
2013-02-07Labeling · Supplement 27 · standardLabelAP
2012-10-18Labeling · Supplement 26 · unknownLetterAP
2012-03-24Labeling · Supplement 22 · unknownLabelAP
2011-06-10Labeling · Supplement 15 · unknownLetterAP
2011-04-14Labeling · Supplement 16 · unknownLetterAP
2010-09-24Labeling · Supplement 18 · unknownLetterAP
2010-09-24Efficacy · Supplement 14 · standardLabelAP
2010-02-26Efficacy · Supplement 12 · standardLetterAP
2010-02-26Efficacy · Supplement 10 · standardLetterAP
2010-02-26Labeling · Supplement 13 · 901 requiredLetterAP
2009-12-28Labeling · Supplement 11 · 901 requiredLabelAP
2008-10-20Labeling · Supplement 9 · standardLetterAP
2008-05-01Manufacturing (CMC) · Supplement 7 · standardLetterAP
2008-02-26Efficacy · Supplement 4 · unknownLabelAP
2008-02-26Efficacy · Supplement 3 · unknownLabelAP
2008-01-02Labeling · Supplement 6 · standardLabelAP
2008-01-02Labeling · Supplement 2 · standardLetterAP
2008-01-02Labeling · Supplement 5 · standardLetterAP
2007-10-11Manufacturing (CMC) · Supplement 1AP
2007-03-30Type 4 - New Combination · Original · standardOther Important Information from FDAAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →